Bayer faces $2 billion verdict on Roundup as it already makes plans to put glyphosate-related lawsuits in rear-view mirror.

The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.

Menopause-related health problems, both physical and mental, have become a pressing issue for women at the transformative age ...

FMC Corporation FMC recently entered into a partnership with Bayer to bring Isoflex active herbicide technology to the ...

The jury called for $2 billion in punitive damages, but previous multibillion-dollar verdicts over Roundup were drastically ...

FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced an agreement with Bayer to commercialize products containing Isoflex™ active in the European Union (EU) and ...

Bayer said it was ordered to pay $2.1 billion in a case about its Roundup weedkiller after a jury in a Georgia state court ...

Bayer was ordered by a Georgia jury to pay about $2.1 billion to a plaintiff who claims Roundup weed killer caused his cancer ...

according to a farmer group and a statement sent by the company to stakeholders this week. Exclusive: Bayer share drop draws market regulator's scrutiny, source says Germany's financial markets ...

Brian Naber says growing up in a farming family in southwest Minnesota helped prepare him for the rigors of leading the ...

FMC), a leading global agricultural sciences company, today announced an agreement with Bayer to commercialize products containing Isoflex™ active in the European Union (EU) and Great Britain.